- Lovastatin derivative dehydrolovastatin ameliorates ulcerative colitis in mice by suppressing NF-κB and inflammatory cytokine expression
-
Zhang X, Deng QH, Deng JH, Wang SJ, Chen Q
- KMID: 2471035
- Korean J Physiol Pharmacol.
- 2020 Mar;24(2):137-147.
- doi: 10.4196/kjpp.2020.24.2.137
Ulcerative colitis (UC) is associated with intestinal immune imbalance and inflammatory response. Because dehydrolovastatin (DLVT), a derivative of lovastatin, has been recently shown to inhibit inflammation and relieve immune arthritis... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
-
Jun JE, Jeong IK, Yu JM, Kim SR, Lee IK, Han KA, Choi SH, Kim SK, Park HK, Mok JO, Lee YH, Kwon HS, Kim SH, Kang HC, Lee SA, Lee CB, Choi KM, Her SH, Shin WY, Shin MS, Ahn HS, Kang SH, Cho JM, Jo SH, Cha TJ, Kim SY, Won KH, Kim DB, Lee JH, Lee MK
- KMID: 2470957
- Diabetes Metab J.
- 2020 Feb;44(1):78-90.
- doi: 10.4093/dmj.2018.0265
BACKGROUND: Cardiovascular risk remains increased despite optimal low density lipoprotein cholesterol (LDL-C) level induced by intensive statin therapy. Therefore, recent guidelines recommend non-high density lipoprotein cholesterol (non-HDL-C) as a secondary... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Statins for Primary Prevention in the Elderly: Recent Evidence
-
Kim K, Lee SH
- KMID: 2470797
- J Lipid Atheroscler.
- 2020 Jan;9(1):1-7.
- doi: 10.12997/jla.2020.9.1.1
The number of the elderly individuals is steeply increasing, and their absolute cardiovascular risk is higher than that of younger age groups. However, very few statin trials have included elderly... -
- CITED
-
- Close
- SHARE
-
- Close
- Sex disparity in acute ischemic stroke outcomes in Korea
-
Gwak BC, Kim GY, Park HJ, Kwon SM, O SI, Kim DH, Jeong JH, Cha JK
- KMID: 2470470
- J Neurocrit Care.
- 2019 Dec;12(2):92-97.
- doi: 10.18700/jnc.190108
BACKGROUND: It is unclear whether women diagnosed with acute ischemic stroke (AIS) have worse outcome after adjusting for several confounding factors such as age, initial stroke severity, and risk factors.... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Antiplatelets Combined with Statins in Patients with Ischemic Heart Disease
-
Kim C, Lee J, Park RW, Lee S
- KMID: 2470463
- Korean J Clin Pharm.
- 2019 Dec;29(4):254-266.
- doi: 10.24304/kjcp.2019.29.4.254
BACKGROUND: Patients with cardiovascular risks are recommended to use statins and antiplatelet agents to prevent major cerebrocardiovascular events (MACCE). Antiplatelet agents also possess anti-inflammatory and antioxidant effects, in addition to... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Statin Use on Liver Cancer Mortality Considering Hypercholesterolemia and Obesity in Patients with Non-Cirrhotic Chronic Hepatitis B
-
Kim GA, Shim JJ, Lee JS, Kim BH, Kim JW, Oh CH, Oh CM, Oh IH, Park SY
- KMID: 2463800
- Yonsei Med J.
- 2019 Dec;60(12):1203-1208.
- doi: 10.3349/ymj.2019.60.12.1203
Little is known about the benefits of statin use on liver cancer mortality among patients with chronic hepatitis B (CHB) considering hypercholesterolemia and obesity. A nationwide retrospective cohort study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Characteristics of Acute Cerebral Infarction in Patients with Familial Hypercholesterolemia
-
Kim J, Park SH, Kim JM, Lee SH, Park KY
- KMID: 2464139
- J Korean Neurol Assoc.
- 2019 Nov;37(4):361-367.
- doi: 10.17340/jkna.2019.4.4
BACKGROUND: The patients with familial hypercholesterolemia (FH) suffer from early onset atherosclerotic vascular disease due to high level of cholesterol and subsequent vascular inflammation, especially in the form of coronary... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study
-
Nam CW, Kim DS, Li J, Baccara-Dinet MT, Li I, Kim JH, Kim CJ
- KMID: 2463483
- Korean J Intern Med.
- 2019 Nov;34(6):1252-1262.
- doi: 10.3904/kjim.2018.133
BACKGROUND/AIMS: Efficacy and safety data of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9), is not yet well established in the Korean population. We assessed... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of short-term atorvastatin use in patients with calcium stones: A randomized placebo-controlled clinical trial
-
Taheri F, Taheri M, Basiri A, Khoshdel A, Samadian F, Tavasoli S
- KMID: 2461059
- Investig Clin Urol.
- 2019 Nov;60(6):472-479.
- doi: 10.4111/icu.2019.60.6.472
PURPOSE: A few experimental and observational studies have reported that atorvastatin prevents calcium oxalate stone formation. Our study is the first to investigate the effect of atorvastatin on 24-hour urinary... -
- CITED
-
- Close
- SHARE
-
- Close
- Study of probiotic and simvastatin additive effect on Helicobacter pylori eradication rate
-
Parsi A, Biuseh M, Mohammadi , Hajiani E, Hashemi SJ, Saeidian H, Biuseh M
- KMID: 2464707
- Int J Gastrointest Interv.
- 2019 Oct;8(4):160-164.
- doi: 10.18528/ijgii190003a
BACKGROUND: Helicobacter pylori infection is a major cause of chronic gastritis, peptic, mucosa associated lymphoid tissueMisdiagnosed as lymphoma and gastric cancer. The eradication rate of H. pylori with standard treatments... -
- CITED
-
- Close
- SHARE
-
- Close
- Lipid-Lowering Therapy Guidelines
-
Lee SH
- KMID: 2462823
- Korean J Med.
- 2019 Oct;94(5):396-402.
- doi: 10.3904/kjm.2019.94.5.396
The major guidelines for lipid-lowering therapy (LLT) have been revised recently. Although “higher cardiovascular risk-aggressive LLT with greater absolute clinical benefit†is the main idea underlying all guidelines, there are... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Transforming Growth Factor-Beta1 and Lovastatin on Differentiating Mesenchymal Stem Cells toward Nucleus Pulposus-like Phenotype: An In Vitro Cell Culture Study
-
Yang SH, Yang KC, Chen CW, Huang TC, Sun YH, Hu MH
- KMID: 2461998
- Asian Spine J.
- 2019 Oct;13(5):705-712.
- doi: 10.31616/asj.2018.0257
STUDY DESIGN: In Vitro cell culture study. PURPOSE: This study aims to investigate the impact of transforming growth factor-beta1 (TGF-β1) and lovastatin on differentiating human mesenchymal stem cells (MSCs) toward nucleus... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus
-
Hwang YC, Jun JE, Jeong IK, Ahn KJ, Chung HY
- KMID: 2460952
- Diabetes Metab J.
- 2019 Oct;43(5):582-589.
- doi: 10.4093/dmj.2018.0124
BACKGROUND: The apolipoprotein B/A1 (apoB/A1) ratio is a stronger predictor of future cardiovascular disease than is the level of conventional lipids. Statin and ezetimibe combination therapy have shown additional cardioprotective... -
- CITED
-
- Close
- SHARE
-
- Close
- Regression of asymptomatic intracranial arterial stenosis by aggressive medical management with a lipid-lowering agent
-
Kim BS, Lim JS, Jeong JU, Mun JH, Kim SH
- KMID: 2465244
- J Cerebrovasc Endovasc Neurosurg.
- 2019 Sep;21(3):144-151.
- doi: 10.7461/jcen.2019.21.3.144
OBJECTIVE: The incidence rate of stroke as a result of intracranial arterial stenosis (ICAS) is higher in Asian countries than in the West. We aimed to analyze the regression, lack... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Variables and Genetic Risk Factors Associated with the Acute Outcome of Ischemic Stroke: A Systematic Review
-
Torres-Aguila NP, Carrera C, Muiño E, Cullell N, Cárcel-Márquez J, Gallego-Fabrega C, González-Sánchez J, Bustamante A, Delgado P, Ibañez L, Heitsch L, Krupinski , Montaner J, MartÃ-Fà bregas J, Cruchaga C, Lee JM, Fernandez-Cadenas I, Acute Endophenotypes Group of the International Stroke Genetics Consortium (ISGC)
- KMID: 2464645
- J Stroke.
- 2019 Sep;21(3):276-289.
- doi: 10.5853/jos.2019.01522
Stroke is a complex disease and one of the main causes of morbidity and mortality among the adult population. A huge variety of factors is known to influence patient outcome,... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of metformin and statin medications with surrogate measures of cardiovascular disease in youth with type 1 diabetes: the SEARCH for diabetes in youth study
-
Gourgari E, Stafford J, D'Agostino R, Dolan LM, Lawrence J, Mottl A, Pihoker C, Urbina EM, Wadwa RP, Dabelea D
- KMID: 2460766
- Ann Pediatr Endocrinol Metab.
- 2019 Sep;24(3):187-194.
- doi: 10.6065/apem.2019.24.3.187
PURPOSE: Youth with type 1 diabetes mellitus (T1DM) are at risk of cardiovascular disease (CVD). We evaluated if metformin or statin use was associated with surrogate measures of improved CVD. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Dyslipidemia and Rate of Under-Target Low-Density Lipoprotein-Cholesterol in Patients with Coronary Artery Disease in Korea
-
Lee SH, Song WH, Jeong MH, Hur SH, Jeon DW, Jeung W, Gitt AK, Horack M, Vyas A, Lautsch D, Ambegaonkar B, Brudi P, Jang Y
- KMID: 2458389
- J Lipid Atheroscler.
- 2019 Sep;8(2):242-251.
- doi: 10.12997/jla.2019.8.2.242
OBJECTIVE: The aim of this study was to evaluate under target rates of low-density lipoprotein-cholesterol (LDL-C) in Korean patients with stable coronary artery disease (CAD) or an acute coronary syndrome... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Prescription Omega-3 Fatty Acids Added to Stable Statin Therapy in Korean Patients with Type 2 Diabetes and Hypertriglyceridemia: a Randomized Controlled Trial
-
Son JW, Kim CH, Nam MS, Park IB, Yoo SJ
- KMID: 2458387
- J Lipid Atheroscler.
- 2019 Sep;8(2):221-231.
- doi: 10.12997/jla.2019.8.2.221
OBJECTIVE: The aim of this study was to investigate the effects of omega-3 fatty acids added to statin monotherapy in Korean patients with type 2 diabetes who have persistent hypertriglyceridemia... -
- CITED
-
- Close
- SHARE
-
- Close
- Intensity of Statin Treatment in Korean Patients with Acute Myocardial Infarction and Very Low LDL Cholesterol
-
Sim DS, Jeong MH, Kim HS, Gwon HC, Seung KB, Rha SW, Chae SC, Kim CJ, Cha KS, Park JS, Yoon JH, Chae JK, Joo SJ, Choi DJ, Hur SH, Seong IW, Cho MC, Kim DI, Oh SK, Ahn TH, Hwang JY, on behalf of the Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH) registry investigators
- KMID: 2458386
- J Lipid Atheroscler.
- 2019 Sep;8(2):208-220.
- doi: 10.12997/jla.2019.8.2.208
OBJECTIVE: Data on the intensity of statin therapy for patients with acute myocardial infarction (MI) and very low baseline low-density lipoprotein (LDL) cholesterol level are lacking. We sought to assess... -
- CITED
-
- Close
- SHARE
-
- Close
- Should We Intensify Statin Management in ACS Patients with Very Low LDL Cholesterol Levels?
-
Han KH
- KMID: 2458385
- J Lipid Atheroscler.
- 2019 Sep;8(2):204-207.
- doi: 10.12997/jla.2019.8.2.204
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
